SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-23-007644
Filing Date
2023-10-16
Accepted
2023-10-16 07:00:29
Documents
15
Period of Report
2023-10-11
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ivbt_8k.htm   iXBRL 8-K 22607
2 PROMISSORY NOTE ivbt_ex41.htm EX-4.1 6215
  Complete submission text file 0001477932-23-007644.txt   144397

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ivbt-20231011.xsd EX-101.SCH 5720
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ivbt-20231011_lab.xml EX-101.LAB 13171
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ivbt-20231011_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ivbt-20231011_pre.xml EX-101.PRE 8249
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ivbt-20231011_def.xml EX-101.DEF 2099
9 EXTRACTED XBRL INSTANCE DOCUMENT ivbt_8k_htm.xml XML 3281
Mailing Address 179 RTE 46W, SUITE 15 #147 ROCKAWAY NJ 07866
Business Address 179 RTE 46W, SUITE 15 #147 ROCKAWAY NJ 07866 929-459-4966
Innovation1 Biotech Inc. (Filer) CIK: 0001629205 (see all company filings)

IRS No.: 822275255 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-55852 | Film No.: 231326181
SIC: 2834 Pharmaceutical Preparations